Centaur Healthcare LimitedDissolved
Registered name: CENTAUR HEALTHCARE LIMITED
Centaur Healthcare Limited made £0 revenue and £9.6k profit in the year to 31 Oct 2023.
Centaur Healthcare Limited’s revenue was £0 in the year to 31 Oct 2023, with £9.6k profit and 0 employees. The company was classified under “manufacture of basic pharmaceutical products” and was based in London; we hold 2 years of its filed accounts. It is no longer on the Companies House register.
- Status
- Dissolved
- Last location
- London
- Age
- 14 yrs · since 2012
Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.
Key figures
Unusual figures. Profit is higher than revenue in this filing. That usually means investment income, dividends from subsidiaries or one-off gains — or a mis-tagged figure. Check the original filing before drawing conclusions.
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Oct 2022 | 31 Oct 2023 |
|---|---|---|
| Disclosure | Full P&L | Full P&L |
| Profit & loss | ||
| Revenue (turnover) | £0 | £0 |
| Profit before tax | −£2.1k | £9.6k |
| Profit after tax | −£2.1k | £9.6k |
| Profit (best available) | −£2.1k | £9.6k |
| Employees (average) | 0 | 0 |
| Ratios | ||
| Profit margin | — | — |
| Balance sheet — indirect signals, not revenue | ||
| Cash at bank | £3.2k | £3k |
| Net assets | £232k | £242k |
| Current assets | £3.2k | £3k |
| Debtors | £5 | £5 |
| Deferred income | £1.4k | £0 |
| Source | FullAccounts · bulk data Oct 2024 | FullAccounts · bulk data Oct 2024 |
How the business works
- Profit margin
- —
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- —
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲4%
- Now £242k
- Cash at bank
- ▼4%
- Now £3k
- Headcount
- —
- Now 0
- Deferred income
- ▼100%
- Now £0
- Fixed assets
- —
- Now —
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Subsidiaries (1)
- Surepharm Services LimitedLiquidationRev. £11.9m · Profit −£966k
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from FullAccounts for the year to 31 Oct 2023 (profit £9.6k), from the Companies House accounts bulk data published Oct 2024. Spotted an error? Request a correction.
Updated from Companies House on 15 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.